Hitting the Target: Updates and Review in Genotype Directed Therapy for Non-Small Cell Lung Cancer

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 75 Minutes

Overview

The development of targeted therapy is an important advancement in cancer treatment. This session will review the application of next generation sequencing in oncology and compare testing methods. Participants will explore oncogenic driver mutations and FDA-approved targeted therapies in non-small cell lung cancer, along with management approaches for toxicities related to tyrosine kinase inhibitors. 

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

1. Explain the basic scientific principles used in next generation sequencing (NGS) and its application in oncology to identify relevant variants or mutations

2. Describe tissue-based and ctDNA testing methods and the advantages and disadvantages of each 

3. Discuss the Non-Small Cell Lung Cancer (NSCLC) mutations with FDA approved therapies within the NSCLC treatment landscape

4. Recognize the diagnosis and management of commonly encountered toxicities for select Tyrosine Kinase Inhibitors (TKIs)                                                                                                                                

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
Course opens: 
04/19/2024
Course expires: 
04/19/2025
Cost:
$0.00
Rating: 
0

Faculty

Jonathan David McGuirt PA-C, MPH 

Jonathan “Jon” McGuirt is a Physician Assistant practicing at the Novant Health Cancer Institute in Winston Salem, NC.  He took a rather circuitous path to becoming a PA, first getting his MPH from the University of South Carolina in 2010. After working 6 years in Charleston, SC he moved to NC to attend Wake Forest and graduated in 2018.  He has practiced in oncology since then, with a current focus on thoracic and neuro-oncology.  When he is not in clinic, he enjoys spending time outdoors with his wife and spoiling their 5 fur-children (and one hedgehog).  Outside of medicine, his loves include travel, coffee, and bashing the drums for the Winston Salem based punk band Hey Revolver. 

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Jonathan David McGuirt discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 24 months.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above